Half-Year 2022 Financial and Clinical Trials Update

Diagnostics Division sales growth by quarter Strong COVID-19 sales and base business growth Diagnostics Division sales growth -Base business sales growth' 55% 48% Roche 28% 31% 24% 18% 17% 18% 9% 10% 5% 2% 3% 11% -2% 1% 8% -5% 0% Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 -17% 0.1bn 0.6bn 0.6bn 1.1bn 1.2bn 1.3bn 1.0bn 1.2bn 1.9bn 1.2bn COVID-19 sales Growth rates at CER (Constant exchange Rates); 1 Quarterly sales growth excluding COVID-19 sales 38 58

View entire presentation